Broken String Biosciences

Broken String Biosciences is leading the way in improving the safety and effectiveness of gene editing therapies. This advancement is crucial in making transformative treatments safe and accessible for patients.

Felix Dobbs, co-founder and the CEO of Broken String Biosciences is the primary inventor of Broken String’s DNA break mapping technology INDUCE-seq™ and holds an AstraZeneca-sponsored PhD in CRISPR genome editing and genomics from Cardiff University.